Schizophrenia Market Research Reports

Schizophrenia Market Research

Schizophrenia is a severe, lifelong brain disorder. People who have it may hear voices, see things that aren’t ... view more

RSS Sort By :
TITLE Price Buy Now More options

"Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Insight, 2018” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cognitive Impairment Associ...

$ 1500


DelveInsight's "Schizophrenia - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Schizophrenia epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. ...

$ 3250


DelveInsight's "Schizophrenia - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Schizophrenia epidemiology and market outlook for the 7MM. Markets Covered - United States...

$ 6250


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2018, provides an overview of the Cognitive Impairment Associated With Schizophrenia (...

$ 2000


In this report, the United States Schizophrenia Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report sp...

$ 3800


In this report, the global Schizophrenia Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split glo...

$ 4000


This report studies Schizophrenia Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022....

$ 3500


In this report, the global Schizophrenia Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmen...

$ 2900


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia - Pipeline Review, H2 2017, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape.Schizophrenia is a chronic, severe,...

$ 2000


This report studies the global Schizophrenia Therapeutics market, analyzes and researches the Schizophrenia Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top play...

$ 3300


Schizophrenia is a chronic mental disorder that alters the perception, thinking, and social behavior of an individual. Individuals suffering from this disease face difficulty in distinguishing between imaginary things and reality. Although schizop...

$ 3500


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2017, provides an overview of the Cognitive Impairment Associated With Schizophrenia (...

$ 2000


Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Tri...

$ 2500


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia - Pipeline Review, H1 2017, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape.Schizophrenia is a chronic, severe,...

$ 2000


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cognitive Impairment Associated With Schizophrenia (CIAS) – Pipeline Review, H1 2017, provides an overview of the Cognitive Impairment Associated With Schizophrenia (...

$ 2000


Notes: Sales, means the sales volume of Schizophrenia Drug Revenue, means the sales value of Schizophrenia Drug This report studies sales (consumption) of Schizophrenia Drug in United States market, focuses on the top pla...

$ 3800


Notes: Production, means the output of Schizophrenia Drug Revenue, means the sales value of Schizophrenia Drug This report studies Schizophrenia Drug in Global market, especially in North America, Europe, China, Japan, So...

$ 2900


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia – Pipeline Review, H2 2016, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape.Schizophrenia is a chronic, severe,...

$ 2000


Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized by several symptom domains including positive symptoms (such as hallucinations or delusions and disorganized...

$ 10995


*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase. GlobalData has released its pharma report, "Schizophrenia - Current and Future Players". The report is a vital source ...

$ 2995

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: